BUSINESSCipla to Invest €15 Million in Ethris, mRNA-based TherapiesNileshDecember 30, 2022December 30, 2022 by NileshDecember 30, 2022December 30, 202201728 Cipla’s wholly owned UK arm has contracted in Ethris worth €15 million, a universal leader in transporting mRNAs directly to the respiratory system with administration...